SuperworthArq price to free cash flow ARQ
Market value divided by free cash flow over the last twelve months, since 2019.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 10.5×
- Nov 2022
- 7-year median
- 3.1×
- 7-year range
- 1.5× to 54.2×
- Peer median
- 4.9×
Arq's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in Nov 2022, at 10.5×.
On the days it had one over the last 7 years, its median was 3.1×, from 1.5× in Jul 2020 to 54.2× in May 2019.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2022 | 10.5× | 3.1× | 24.1× |
| 2021 | 3.4× | 1.8× | 3.9× |
| 2020 | 2.4× | 1.5× | 6.4× |
| 2019 | 5.3× | 5.2× | 54.2× |
Against its peers
Companies in Chemicals nearest Arq's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ARQArq | n/m |
| FTLFFitlife Brands | 7.8× |
| BTMDbiote | 1.9× |
| NAGENiagen Bioscience | n/m |
| Peer median | 4.9× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Arq
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.